http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109966281-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285 |
| filingDate | 2019-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109966281-B |
| titleOfInvention | Application of PAO (platelet activating factor) as Pi4KII alpha inhibitor in preparation of medicine for treating post-traumatic stress disorder |
| abstract | The invention discloses an application of PAO as a Pi4KII alpha inhibitor in preparing a medicament for treating post-traumatic stress disorder. Specifically, the invention provides an application of a Pi4KII alpha inhibitor in preparing a medicament for treating post-traumatic stress disorder, wherein the Pi4KII alpha inhibitor can be phenylarsene oxide; the invention also provides a drug for treating post-traumatic stress disorder, the active ingredient of the drug is Pi4KII alpha inhibitor, and the Pi4KII alpha inhibitor can be arsenic oxide. The Pi4KII alpha inhibitor (arsenic oxide) is used as an active ingredient for preparing the medicine for treating post-traumatic stress disorder, and has the advantages of quick response, good curative effect and small side effect. The invention has great application value for treating post-traumatic stress disorder. |
| priorityDate | 2019-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.